| Peter R Coelho M D Inc | |
|
9460 N Name Uno Suite 115 Gilroy CA 95020-3537 | |
| (408) 707-0234 | |
| Not Available |
| Full Name | Peter R Coelho M D Inc |
|---|---|
| Speciality | Family Medicine |
| Location | 9460 N Name Uno, Gilroy, California |
| Authorized Official Name and Position | Peter Robert Coelho (OWNER) |
| Authorized Official Contact | 4087070234 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Peter R Coelho M D Inc Po Box 2562 Hollister CA 95024-2562 Ph: (831) 801-3003 | Peter R Coelho M D Inc 9460 N Name Uno Suite 115 Gilroy CA 95020-3537 Ph: (408) 707-0234 |
| NPI Number | 1679772982 |
|---|---|
| Provider Enumeration Date | 07/16/2007 |
| Last Update Date | 05/17/2017 |
| Medicare PECOS PAC ID | 7911943790 |
|---|---|
| Medicare Enrollment ID | O20100630000708 |
News Archive
CytomX Therapeutics, a biopharmaceutical company developing investigational Probody™ therapeutics for the treatment of cancer, today entered into a collaboration with The University of Texas MD Anderson Cancer Center to research Probody-enabled chimeric antigen receptor natural killer (CAR-NK) cell therapies, to be known as ProCAR-NK cell therapies.
In this post on the State Department's DipNote blog, U.S. Ambassador to Haiti Kenneth Merten discusses the June 26 signing of the Partnership Framework to support Haiti's Health Strategy between the Government of Haiti (GOH) and the U.S. Government (USG).
The COVID-19 pandemic heavily influenced spending on prescription drugs in the U.S. in 2020, according to the ASHP's (American Society of Health-System Pharmacists) National Trends in Prescription Drug Expenditures and Projections for 2021.
Idera Pharmaceuticals, Inc. today announced the issuance of patents covering compositions and methods of using its synthetic immune modulatory oligonucleotides targeted to Toll-like receptors (TLRs). The Company's intellectual property portfolio currently contains over 500 patents and patent applications worldwide and includes claims for TLR-targeted compounds, second-generation antisense chemistry, and oral delivery of certain oligonucleotides.
› Verified 9 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1679772982 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | A71852 (California) | Primary |
| Provider Name | Peter Robert Coelho |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1285740480 PECOS PAC ID: 0941331243 Enrollment ID: I20100630000746 |
News Archive
CytomX Therapeutics, a biopharmaceutical company developing investigational Probody™ therapeutics for the treatment of cancer, today entered into a collaboration with The University of Texas MD Anderson Cancer Center to research Probody-enabled chimeric antigen receptor natural killer (CAR-NK) cell therapies, to be known as ProCAR-NK cell therapies.
In this post on the State Department's DipNote blog, U.S. Ambassador to Haiti Kenneth Merten discusses the June 26 signing of the Partnership Framework to support Haiti's Health Strategy between the Government of Haiti (GOH) and the U.S. Government (USG).
The COVID-19 pandemic heavily influenced spending on prescription drugs in the U.S. in 2020, according to the ASHP's (American Society of Health-System Pharmacists) National Trends in Prescription Drug Expenditures and Projections for 2021.
Idera Pharmaceuticals, Inc. today announced the issuance of patents covering compositions and methods of using its synthetic immune modulatory oligonucleotides targeted to Toll-like receptors (TLRs). The Company's intellectual property portfolio currently contains over 500 patents and patent applications worldwide and includes claims for TLR-targeted compounds, second-generation antisense chemistry, and oral delivery of certain oligonucleotides.
› Verified 9 days ago
News Archive
CytomX Therapeutics, a biopharmaceutical company developing investigational Probody™ therapeutics for the treatment of cancer, today entered into a collaboration with The University of Texas MD Anderson Cancer Center to research Probody-enabled chimeric antigen receptor natural killer (CAR-NK) cell therapies, to be known as ProCAR-NK cell therapies.
In this post on the State Department's DipNote blog, U.S. Ambassador to Haiti Kenneth Merten discusses the June 26 signing of the Partnership Framework to support Haiti's Health Strategy between the Government of Haiti (GOH) and the U.S. Government (USG).
The COVID-19 pandemic heavily influenced spending on prescription drugs in the U.S. in 2020, according to the ASHP's (American Society of Health-System Pharmacists) National Trends in Prescription Drug Expenditures and Projections for 2021.
Idera Pharmaceuticals, Inc. today announced the issuance of patents covering compositions and methods of using its synthetic immune modulatory oligonucleotides targeted to Toll-like receptors (TLRs). The Company's intellectual property portfolio currently contains over 500 patents and patent applications worldwide and includes claims for TLR-targeted compounds, second-generation antisense chemistry, and oral delivery of certain oligonucleotides.
› Verified 9 days ago
Planned Parenthood Mar Monte, Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 760 Renz Lane, Gilroy, CA 95020 Phone: 408-847-1739 Fax: 408-847-5146 | |
Vhc At Gilroy Bcp Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 7475 Camino Arroyo, Gilroy, CA 95020 Phone: 408-885-5000 | |
Vhc At Gilroy Hap Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 7475 Camino Arroyo, Gilroy, CA 95020 Phone: 408-885-5000 | |
Foothill Community Health Center Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 9460 No Name Uno, Suite 110, Gilroy, CA 95020 Phone: 408-797-2500 Fax: 866-931-7822 | |
California Emergency Physicians Medical Group Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 8833 Monterey Rd, Suite H, Gilroy, CA 95020 Phone: 408-842-1544 | |
South Valley Primary Care Group Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 9460 N Name Uno, Suite 110, Gilroy, CA 95020 Phone: 831-676-6766 | |
Foothill Health Center, Inc. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 9460 N Name Uno, Suite 215, Gilroy, CA 95020 Phone: 408-797-2510 Fax: 408-963-0143 |